Related Experiment Video
Updated: Jun 12, 2025
Working with Human Tissues for Translational Cancer Research
Published on: November 26, 2015
Tackling Predatory Journals in Oncology: Training Is Key!
Salma Najem1, Hind Mrabti1, Hassan Errihani1
1Salma Najem, MD, Hind Mrabti, MD, and Hassan Errihani, MD, Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco, Faculty of Medicine and Pharmacy, Mohamed V University, Rabat, Morocco.
Predatory journals threaten oncology research integrity. This correspondence addresses this global issue and proposes evidence-based solutions to safeguard scientific standards.
Area of Science:
- Oncology
- Scientific Publishing Ethics
Background:
- Predatory journals pose a significant global threat to the integrity of oncology research.
- The proliferation of predatory journals undermines evidence-based guidelines and recommendations in cancer research.
Discussion:
- This correspondence critically examines the multifaceted problem of predatory publishing in oncology.
- It highlights the urgent need to address the erosion of research integrity caused by these journals.
Key Insights:
- Predatory journals compromise the reliability of oncology research findings.
- Maintaining the integrity of evidence-based oncology guidelines is paramount.
Outlook:
- Proposes actionable solutions to combat predatory publishing in oncology.
- Aims to strengthen the standards and credibility of scientific oncology literature.
More Related Videos
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
08:29Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics
Published on: October 2, 2014
Related Concept Videos
02:18Cancer
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistant Cancers
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...